NCT03062397 - Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

December 9, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2021

Conditions

Acute Ischemic Stroke

Interventions

DRUG

JPI-289 Low-dose

JPI-289 Low dose will be intravenously administered during 24 hours

DRUG

JPI-289 High-dose

JPI-289 High dose will be intravenously administered during 24 hours

DRUG

Placebo

Same dosage of JPI-289 Low and Hogh dose will be intravenously administered during 24 hours

Trial Locations (15)

Unknown

RECRUITING

Dong-A University Hospital, Busan

RECRUITING

Inje University Busan Paik Hospital, Busan

RECRUITING

Gyeongsang National University Changwon Hospital, Changwon

RECRUITING

Yeungnam University Medical Center, Daegu

RECRUITING

Chonnam National University Hospital, Gwangju

RECRUITING

Inje University Ilsan Paik Hospital, Gyeonggi-do

RECRUITING

Seoul National University Bundang Hospital, Gyeonggi-do

RECRUITING

Catholic Kwandong University International St. Mary'S Hospital, Incheon

RECRUITING

Jeju National University Hospital, Jeju City

RECRUITING

Gyeongsang National University Hospital, Jinju

RECRUITING

Pusan National University Hospital, Pusan

RECRUITING

Ewha Womans University Seoul Hospital, Seoul

RECRUITING

Hanyang University Hospital, Seoul

RECRUITING

Korea University Guro Hospital, Seoul

RECRUITING

Seoul National University Hospital, Seoul